OpenExamsFREE PRACTICE — ANY EXAM

Oregon Pharmacist — Requirements & Free Practice

US-OR · License preparation

300 free questions · Answer explanations · No signup required

Choose what to practice

Start with an exam below. Your examination requirements depend on your application pathway. View licensing requirements

Combined practice

Choose an exam or combined practice to begin.

Licenses, application pathways and examination requirements

Each license and applicant pathway has its own requirements and exemptions. Choosing practice questions does not determine your eligibility.

Pharmacist

License to engage in the practice of pharmacy in Oregon, issued by the Oregon Board of Pharmacy under ORS 689.225 and OAR 855 Division 115, by examination, NAPLEX score transfer or reciprocity.

Licensing authority: Oregon Board of Pharmacy · Application information

Licensure by examination (NAPLEX taken with Oregon as the primary state)

All of the following:

Age And Character
ORS 689.255(1)(b)-(c): at least 18 years of age and of good moral character and temperate habits.
Background And Application
OAR 855-115-0030(2): completed application with fee, photograph and proof of identity, a completed national fingerprint-based background check, and a moral turpitude statement or disclosure documentation.
Education
OAR 855-115-0020(1)(a)(A): official transcript showing a degree conferred by an ACPE-accredited college or school of pharmacy, or compliance with OAR 855-115-0015.
Exam Score Validity
OAR 855-115-0020(1)(b)-(c): passing NAPLEX and Oregon MPJE results are valid for 12 months; retakes after 45 days (NAPLEX) or 30 days (MPJE), at most three attempts in 12 months and a lifetime maximum of 5 failed attempts.
Foreign Graduates
OAR 855-115-0010(3) and 855-115-0015: a graduate of a foreign pharmacy school must obtain certification from the Foreign Pharmacy Graduate Examination Committee (FPGEC), except listed CCAPP (1993 to June 30, 2004) and Lebanese American University (after 2002) graduates, and submit evidence of 1440 hours of US pharmacy practice as an intern or pharmacist completed after FPGEC certification.
Internship
OAR 855-115-0020(1)(a)(B): completion of a minimum of 1440 hours in an Internship Program.
Lawful Presence
OAR 855-115-0010(2): if residing in the United States, proof of citizenship, legal permanent residency or qualifying visa as required by 8 USC 1621.
Naplex Jurisdiction
Board page: the NAPLEX was taken with Oregon as the primary state.
Pain Management CPE
OAR 855-115-0030(2)(b)(D): certificate of completion of one hour of continuing pharmacy education in pain management provided by the Pain Management Commission of the Oregon Health Authority.
Pre2011Graduates
Board page: an applicant who graduated before 2011 and has never been licensed in another state must contact the Board for more information.
Licensure by reciprocity (licensure transfer)

All of the following:

Background And Application
OAR 855-115-0030(2): completed application with fee, photograph and proof of identity, a completed national fingerprint-based background check, and a moral turpitude statement or disclosure documentation.
Education
OAR 855-115-0025(1)(a): graduate of an ACPE-accredited college or school of pharmacy, or compliance with OAR 855-115-0015.
Eligibility At Initial Licensure
ORS 689.265(1)(d): at initial licensure the applicant possessed the qualifications needed to have been eligible for licensure in Oregon at that time.
Experience
ORS 689.265(1)(e) and OAR 855-115-0025(1)(e): at least 12 months of practice including 1440 hours as a licensed pharmacist, or 1440 internship hours within the 12 months before application.
Foreign Graduates
OAR 855-115-0010(3) and 855-115-0015: a graduate of a foreign pharmacy school must obtain certification from the Foreign Pharmacy Graduate Examination Committee (FPGEC), except listed CCAPP (1993 to June 30, 2004) and Lebanese American University (after 2002) graduates, and submit evidence of 1440 hours of US pharmacy practice as an intern or pharmacist completed after FPGEC certification.
Foreign Or Residency Applicants
Board page: a foreign pharmacy graduate or an applicant attending an Oregon PGY1 or PGY2 program who has not been licensed as a pharmacist for one full year must email the Board about applying via reciprocity.
Lawful Presence
OAR 855-115-0010(2): if residing in the United States, proof of citizenship, legal permanent residency or qualifying visa as required by 8 USC 1621.
Mpje Score Validity
OAR 855-115-0025(1)(c): a passing Oregon MPJE result is valid for 12 months.
Pain Management CPE
OAR 855-115-0030(2)(b)(D): certificate of completion of one hour of continuing pharmacy education in pain management provided by the Pain Management Commission of the Oregon Health Authority.
Prior Licensure
ORS 689.265(1)(f) and OAR 855-115-0025(1)(d): proof of initial licensure by examination in another state, and every pharmacist license held is not suspended, revoked, canceled or otherwise restricted except for nonrenewal or missing continuing education where not practicing.
Reciprocal State
ORS 689.265(2): the state of initial licensure must also grant reciprocal licensure to pharmacists licensed by examination in Oregon under like circumstances.
Reinstatement of a license lapsed more than three years (not more than five years, or more than five years while an active pharmacist license was maintained in another US state or jurisdiction)
Oregon Multistate Pharmacy Jurisprudence Examination (MPJE) (practice unavailable)
Alternative Reciprocity
OAR 855-115-0035(6): in lieu of reinstatement, a person with an active pharmacist license in good standing in another US state or jurisdiction may apply by reciprocity.
Application
OAR 855-115-0035(3)(a): apply per OAR 855-115-0030 (application, fee, photograph, identity, fingerprint background check, moral turpitude statement, pain management CPE).
Continuing Education
OAR 855-115-0035(3)(b): certification of the continuing pharmacy education required by OAR 855-135 for all years in which the license was lapsed.
Lapse
OAR 855-115-0035(4)-(5): the license has been lapsed for more than three years; if lapsed more than five years, the person has maintained an active pharmacist license in another US state or jurisdiction.
Mpje Score Validity
OAR 855-115-0035(4): a passing Oregon MPJE result is valid for 12 months; retakes after 30 days, at most three attempts in 12 months and a lifetime maximum of 5 failed attempts.
Retired License
OAR 855-115-0035(7): a license retired for more than 12 months pays only the annual license fees for the year a license is sought and completes the requirements in OAR 855-115-0035(3).
Voluntary Surrender
OAR 855-115-0050(5): a former licensee whose license was voluntarily surrendered applies for reinstatement per OAR 855-115-0035 unless the final order prohibits it.
Reinstatement of a license lapsed more than five years without an active pharmacist license in another US state or jurisdiction

All of the following:

Alternative Reciprocity
OAR 855-115-0035(6): in lieu of reinstatement, a person with an active pharmacist license in good standing in another US state or jurisdiction may apply by reciprocity.
Application
OAR 855-115-0035(3)(a): apply per OAR 855-115-0030 (application, fee, photograph, identity, fingerprint background check, moral turpitude statement, pain management CPE).
Continuing Education
OAR 855-115-0035(3)(b): certification of the continuing pharmacy education required by OAR 855-135 for all years in which the license was lapsed.
Exam Score Validity
OAR 855-115-0035(4)-(5): passing Oregon MPJE and NAPLEX results are valid for 12 months.
Lapse
OAR 855-115-0035(5): the license has been lapsed for more than five years and the person has not maintained an active pharmacist license in another US state or jurisdiction.
Retired License
OAR 855-115-0035(7): a license retired for more than 12 months pays only the annual license fees for the year a license is sought and completes the requirements in OAR 855-115-0035(3).
Voluntary Surrender
OAR 855-115-0050(5): a former licensee whose license was voluntarily surrendered applies for reinstatement per OAR 855-115-0035 unless the final order prohibits it.
Reinstatement of a license lapsed more than 12 months and not more than three years
No examination is required for this applicant pathway.
Alternative Reciprocity
OAR 855-115-0035(6): in lieu of reinstatement, a person with an active pharmacist license in good standing in another US state or jurisdiction may apply by reciprocity.
Application
OAR 855-115-0035(3)(a): apply per OAR 855-115-0030 (application, fee, photograph, identity, fingerprint background check, moral turpitude statement, pain management CPE).
Continuing Education
OAR 855-115-0035(3)(b): certification of the continuing pharmacy education required by OAR 855-135 for all years in which the license was lapsed.
Lapse
OAR 855-115-0035(3)-(4): the license has been lapsed for greater than 12 months and not more than three years, so the Oregon MPJE requirement of OAR 855-115-0035(4) does not apply.
Retired License
OAR 855-115-0035(7): a license retired for more than 12 months pays only the annual license fees for the year a license is sought and completes the requirements in OAR 855-115-0035(3).
Voluntary Surrender
OAR 855-115-0050(5): a former licensee whose license was voluntarily surrendered applies for reinstatement per OAR 855-115-0035 unless the final order prohibits it.

Official no-examination sources

Effective from 2024-03-01.

Biennial renewal, including late renewal of a license lapsed 12 months or less
No examination is required for this applicant pathway.
Background Check
OAR 855-115-0035(1)(c): be subject to a criminal background check.
Continuing Education
OAR 855-115-0035(1)(b): complete the continuing pharmacy education requirements in OAR 855-135.
Disclosure
OAR 855-115-0035(1)(d): provide a written description and documentation of all conduct required to be disclosed.
Late Renewal
OAR 855-115-0035(2): a license lapsed 12 months or less may be renewed with the late fee in OAR 855-110.
License Fee
OAR 855-115-0035(1)(a): pay the biennial license fee in OAR 855-110.

Official no-examination sources

Effective from 2024-03-01.

Licensure by NAPLEX score transfer

All of the following:

Age And Character
ORS 689.255(1)(b)-(c): at least 18 years of age and of good moral character and temperate habits.
Background And Application
OAR 855-115-0030(2): completed application with fee, photograph and proof of identity, a completed national fingerprint-based background check, and a moral turpitude statement or disclosure documentation.
Education
OAR 855-115-0020(1)(a)(A): official transcript showing a degree conferred by an ACPE-accredited college or school of pharmacy, or compliance with OAR 855-115-0015.
Exam Score Validity
OAR 855-115-0020(1)(b)-(c): passing NAPLEX and Oregon MPJE results are valid for 12 months; retakes after 45 days (NAPLEX) or 30 days (MPJE), at most three attempts in 12 months and a lifetime maximum of 5 failed attempts.
Foreign Graduates
OAR 855-115-0010(3) and 855-115-0015: a graduate of a foreign pharmacy school must obtain certification from the Foreign Pharmacy Graduate Examination Committee (FPGEC), except listed CCAPP (1993 to June 30, 2004) and Lebanese American University (after 2002) graduates, and submit evidence of 1440 hours of US pharmacy practice as an intern or pharmacist completed after FPGEC certification.
Internship
OAR 855-115-0020(1)(a)(B): completion of a minimum of 1440 hours in an Internship Program.
Lawful Presence
OAR 855-115-0010(2): if residing in the United States, proof of citizenship, legal permanent residency or qualifying visa as required by 8 USC 1621.
Pain Management CPE
OAR 855-115-0030(2)(b)(D): certificate of completion of one hour of continuing pharmacy education in pain management provided by the Pain Management Commission of the Oregon Health Authority.
Score Transfer
OAR 855-115-0020(3) and Board page: the NAPLEX was taken for a state other than Oregon and the applicant requested NABP to transfer the NAPLEX score to Oregon.

North American Pharmacist Licensure Examination

Provider
National Association of Boards of Pharmacy
Format
Computerized fixed form
Exam questions
225 questions
Time limit
6 hours
Passing score
Pass or Fail
Examination outline
  • Foundational Knowledge for Pharmacy Practice (25%)
    • Pharmaceutical science principles and concepts
    • Pharmaceutical science principles and concepts: Pharmacology
    • Pharmaceutical science principles and concepts: Pharmacokinetics, pharmacodynamics, or pharmacogenomics
    • Pharmaceutical science principles and concepts: Pharmaceutics
    • Pharmaceutical compounding
    • Pharmaceutical compounding: Nonsterile preparations
    • Pharmaceutical compounding: Sterile preparations
    • Pharmaceutical calculations
    • Pharmaceutical calculations: Patient parameters or laboratory measures
    • Pharmaceutical calculations: Quantities of drugs to be dispensed or administered
    • Pharmaceutical calculations: Rates of administration
    • Pharmaceutical calculations: Dose conversions
    • Pharmaceutical calculations: Drug concentrations, ratio strengths, osmolarity, or osmolality
    • Pharmaceutical calculations: Quantities of drugs or ingredients to be compounded
    • Pharmaceutical calculations: Nutritional needs and the content of nutrient sources
    • Pharmaceutical calculations: Biostatistical, epidemiological, or pharmacoeconomic measures
    • Pharmaceutical calculations: Pharmacokinetic parameters
    • Drug development processes (eg, clinical trial phases, emergency use authorizations)
    • Research design principles and biostatistics (eg, blinding, randomization, biases, statistical tests and outcomes, ethics)
    • Retrieval, assessment, and interpretation of primary, secondary, and tertiary resources
  • Medication Use Process (Prescribing, Transcribing and Documenting, Dispensing, Administering, and Monitoring) (25%)
    • Prescriptions and medication order interpretation
    • Prescriptions and medication order interpretation: Drug names and therapeutic classes
    • Prescriptions and medication order interpretation: Indications, usage, and dosing regimens
    • Prescriptions and medication order interpretation: Available dosage forms
    • Prescriptions and medication order interpretation: Prescription regulations (eg, boxed warnings, risk evaluation and mitigation strategies)
    • Prescriptions and medication order interpretation: Safety and effectiveness (eg, laboratory parameters, vital signs)
    • Therapeutic substitutions (eg, formulary restrictions, therapeutic alternatives, shortages, biosimilars)
    • Immunization services and documentation
    • Immunization services and documentation: Indications and scheduling
    • Immunization services and documentation: Contraindications and precautions
    • Immunization services and documentation: Storage and handling
    • Immunization services and documentation: Administration (eg, techniques, preparation, routes)
    • Immunization services and documentation: Adverse reactions
    • Medication handling, storage, stability, and disposal (eg, hazardous and nonhazardous drugs, controlled substances, parenteral medications, sharps handling, temperature control)
  • Person-Centered Assessment and Treatment Planning (40%)
    • Medication history, allergy history, and reconciliation
    • Health histories, screenings, and assessments
    • Patient health conditions, including special populations and medication-related factors
    • Patient health conditions, including special populations and medication-related factors: Signs, symptoms, and findings of medical conditions, etiology of diseases, or pathophysiology
    • Patient health conditions, including special populations and medication-related factors: Appropriateness of therapy (eg, medications, immunizations, non-drug therapy, dosing, contraindications, warnings, evidence-based decision making)
    • Patient health conditions, including special populations and medication-related factors: Interactions (eg, drug-drug, drug-condition, drug-food, drug-allergy, drug-laboratory)
    • Patient health conditions, including special populations and medication-related factors: Errors and omissions (eg, dosing, duplication, additional therapy needed, unnecessary therapy)
    • Patient health conditions, including special populations and medication-related factors: Adverse drug reactions
    • Patient health conditions, including special populations and medication-related factors: Toxicologic exposures and overdoses
    • Patient health conditions, including special populations and medication-related factors: Adherence
    • Therapeutic monitoring, plan development, evaluation, and modifications
    • Therapeutic monitoring, plan development, evaluation, and modifications: Therapeutic goals, clinical endpoints, and follow-up
    • Therapeutic monitoring, plan development, evaluation, and modifications: Safety
    • Therapeutic monitoring, plan development, evaluation, and modifications: Effectiveness
    • Patient education
    • Patient education: Lifestyle modifications and health maintenance
    • Patient education: Medication use, storage, and disposal
    • Patient education: Disease state management
    • Over-the-counter medications and dietary supplements
    • Devices to administer medications and self-monitoring tests
  • Professional Practice (5%)
    • Adverse drug event reporting and medication error reporting (eg, MedWatch, VAERS)
    • Public health initiatives and risk-prevention programs (eg, tobacco and nicotine cessation, antimicrobial stewardship, health screenings, opioid stewardship)
    • Social determinants and drivers of health
    • Ethical considerations (eg, informed consent, ethical principles, professional conduct and responsibility, patient confidentiality)
  • Pharmacy Management and Leadership (5%)
    • Pharmacy operations (eg, operational planning, risk management, regulations and regulatory bodies, technology applications and informatics, error-prevention strategies, medication safety)
    • Inventory and supply management (eg, drug recalls, drug shortages)
    • Quality improvement activities (eg, medication use evaluation, root-cause analysis, continuous quality improvement)
    • Mentorship and preceptorship (eg, providing and receiving feedback, delegation of work activities, preceptor roles)
Examination sources

Oregon Multistate Pharmacy Jurisprudence Examination (MPJE)

Provider
National Association of Boards of Pharmacy (NABP)
Format
Computer-based adaptive exam of selected-response questions
Exam questions
120 questions, of which 100 are scored and 20 are pretest questions
Time limit
2.5 hours (3-hour total appointment)
Examination outline
  • Area 1 — Licensure/Personnel (22%)
    • Responsibilities of the pharmacist and non-pharmacist personnel
    • Qualifications, scope of duties, limitations, and restrictions of duties, or conditions to practice for pharmacists-in-charge (or equivalent) and pharmacists
    • Qualifications, scope of duties, limitations, and restrictions of duties, or conditions to practice for non-pharmacist personnel
    • Licensures, registrations, and certifications for pharmacists or non-pharmacist personnel
    • Qualifications, examinations, internships, maintaining pharmacist competency, and renewals of licensures, registrations, or certifications
    • Classifications and processes of disciplinary actions
    • Reporting to and participating in programs addressing the inability to practice with reasonable skill and safety
  • Area 2 — Pharmacist Practice (33%)
    • Requirements for issuing prescriptions/drug orders
    • Requirements for drug uses, limitations, or restrictions
    • Scope of authority, scope of practice, limitations or restrictions of practice, and valid registration of practitioners who are authorized to prescribe, dispense, or administer drugs
    • Requirements for issuing non-controlled prescriptions/drug orders
    • Requirements for issuing controlled prescriptions/drug orders
    • Authority limitations of practitioners’ ability to authorize refills
    • Conditions under which the pharmacist or non-pharmacist personnel participates in the administration of drugs in the management of patients’ therapy
    • Requirements regarding counseling
    • Counseling or offering to counsel
    • Documenting counseling or documenting offering to counsel
    • Returning or reusing drugs
    • Regulations and agencies regarding pharmacy practice
    • Requirements for promoting quality and safety of public health
    • Protecting patient and health record confidentiality
  • Area 3 — Dispensing Requirements (24%)
    • Responsibilities for determining whether prescriptions/drug orders are issued for a legitimate medical purpose, and within all applicable restrictions
    • Transferring prescription/drug order information between pharmacies by authorized personnel
    • Prospective drug utilization reviews
    • Requirements for reporting to PMP and accessing PMP data
    • Exceptions to dispensing or refilling prescriptions/drug orders
    • Labeling of dispensed drugs
    • Packaging of dispensed drugs
    • Drug product conditions prohibiting dispensing
    • Requirements for the distribution and/or dispensing of non-prescription pharmaceutical products, including controlled substances and hazardous drugs
    • Dispensing or administration
    • Labeling of non-prescription drugs and devices
    • Packaging and repackaging of non-prescription drugs and behind-the-counter products
    • Dispensing-restricted, non-prescription drugs
  • Area 4 — Pharmacy Operations (21%)
    • Ordering, acquisition, and distribution of drugs, including maintenance and content of such records
    • Ordering and acquisition, including the maintenance and content of such records
    • Distribution, including the maintenance and content of such records
    • Recordkeeping in compliance with legal requirements, including content, inventory, maintenance, storage, handling, and reporting
    • Non-dispensing requirements for operations of pharmacies or practice settings
    • Possession, storage, and handling of non-hazardous drugs
    • Training, possession, handling, storage, and disposal of hazardous drugs
    • Allowing non-pharmacist personnel access to drugs
    • Requirements for conducting controlled substance inventories
    • Delivery of drugs
    • Conditions for permitted or mandated product selection
    • Compounding sterile, nonsterile, hazardous, and non-hazardous preparations
    • Centralized prescription processing or central-fill pharmacy dispensing
    • Requirements for the registration, licensure, certification, or permitting of a practice setting or business entity
    • Requirements for registration, license, certification, or permitting of a practice setting
    • Requirements for the renewal or reinstatement of a license, registration, certificate, or permit of a practice setting
    • Requirements for an inspection of a licensed, registered, certified, or permitted practice setting
    • Classifications and processes of disciplinary actions that may be taken against a registered, licensed, certified, or permitted practice setting
Examination sources